Publicaciones en colaboración con investigadores/as de Novo Nordisk (1)

2022

  1. Once-Weekly Semaglutide Use in Patients with Type 2 Diabetes: Results from the SURE Spain Multicentre, Prospective, Observational Study

    Journal of Clinical Medicine, Vol. 11, Núm. 17